The Stalled Ban on Electric Shock Devices: A Medical and Ethical Crisis

For over a decade, the medical and disability rights communities have been embroiled in a contentious battle regarding the use of Graduated Electronic Decelerator (GED) devices. These devices, which deliver painful electric shocks to the skin, are primarily used to manage self-injurious and aggressive behaviors in individuals with intellectual and developmental disabilities. Despite mounting international condemnation and a clear legislative mandate, a federal ban on these devices remains in limbo, leaving families and advocates questioning the FDA’s commitment to patient safety.

The Regulatory Deadlock

The path toward outlawing electric shock devices has been long and legally complex. In 2020, the U.S. Food and Drug Administration (FDA) initially moved to ban the devices, citing an unreasonable and substantial risk of illness or injury. However, that ruling was vacated by a federal appeals court, which ruled that the agency lacked the statutory authority to regulate the practice of medicine in such a manner.

In response, Congress passed the Consolidated Appropriations Act of 2022, which explicitly granted the FDA the authority to prohibit the use of these devices. Despite this legislative green light and a self-imposed deadline that passed in May 2024, the agency has yet to finalize the ban. This silence has caused significant alarm among disability advocates who argue that the continued use of these devices constitutes a violation of fundamental human rights.

Medical and Ethical Perspectives

The use of aversive conditioning, specifically electric shock, is widely condemned by major medical organizations. The American Academy of Pediatrics (AAP) has officially opposed the practice, noting that it is punitive and fails to address the underlying causes of behavioral distress. United Nations officials have characterized the use of these devices as a form of torture, emphasizing that they are incompatible with modern standards of psychiatric care and behavioral intervention.

Modern clinical practice prioritizes Positive Behavior Support (PBS), which focuses on identifying the root causes of self-injury—such as communication deficits, physical pain, or environmental stressors—and teaching functional replacement skills. The continued reliance on aversive stimuli at the Judge Rotenberg Center (JRC) in Massachusetts, the only institution in the U.S. Currently known to use these devices, stands in stark contrast to evidence-based, trauma-informed care.

Key Takeaways

• The Device: The GED device delivers an electric shock to the skin, which is acknowledged by the manufacturer to be painful.
• Regulatory Status: Although Congress authorized the FDA to ban these devices in 2022, the agency has missed its internal deadlines to enact a final rule.
• Professional Consensus: Leading medical and human rights organizations advocate for the immediate cessation of electric shock as a behavioral intervention.
• Patient Impact: Former residents have reported lasting psychological trauma, including symptoms consistent with PTSD, stemming from their time in facilities using aversive shock therapy.

The Human Cost: A Legacy of Trauma

The debate surrounding these devices is not merely a matter of administrative policy; it is a matter of profound human impact. Former residents have shared harrowing accounts of being subjected to shocks for minor infractions, such as speaking out of turn or failing to comply with rigid behavioral protocols. These experiences often leave deep emotional scars that persist well into adulthood.

While proponents of the center argue that the treatment is a “last resort” for individuals who have not responded to other interventions, critics maintain that the severity of the treatment is disproportionate and ethically indefensible. The argument that these devices prevent harm is countered by the reality that the treatment itself inflicts pain and fear, creating a cycle of trauma rather than true behavioral healing.

Moving Forward

The delay in the FDA’s final ruling is increasingly untenable. For the families of individuals currently subjected to these treatments, every day that passes without a ban is a day of continued vulnerability for their loved ones. As an internal medicine physician, I emphasize that clinical interventions must be governed by the principle of “first, do no harm.” When a treatment is widely recognized as causing physical and psychological distress without being supported by modern, evidence-based standards, the medical community has a responsibility to demand its removal from practice.

Public pressure and legislative oversight remain the most effective tools to ensure that the FDA fulfills its mandate. The goal remains clear: the permanent elimination of electric shock devices to ensure that all individuals, regardless of their cognitive or behavioral needs, are treated with dignity, safety, and respect.

Frequently Asked Questions

Is electric shock therapy for behavior the same as ECT?

No. Electroconvulsive therapy (ECT) is a medical procedure used to treat severe depression and other mental health conditions under anesthesia. The devices used for behavioral modification are fundamentally different in purpose, application, and clinical oversight.

Are there alternatives to aversive shock therapy?

Yes. Evidence-based alternatives include functional communication training, environmental modifications, and pharmacological interventions managed by board-certified psychiatrists, all of which prioritize patient well-being and autonomy.

Why does the FDA have the power to ban this?

The FDA regulates medical devices. If the agency determines that a device presents an unreasonable and substantial risk of illness or injury that cannot be corrected by labeling or other means, it has the authority to ban that device from the market.